1001233--3/16/2006--SANGAMO_BIOSCIENCES_INC

related topics
{product, candidate, development}
{investment, property, distribution}
Our collaborators may control aspects of our clinical trials, which could result in delays and other obstacles in the commercialization of our proposed products. We may not be able to find acceptable patients or may experience delays in enrolling patients for our clinical trials. We may be unable to license gene transfer technologies that we may need to commercialize our ZFP TF technology. Commercialization of our technologies will depend, in part, on strategic partnering with other companies. If we are not able to find strategic partners in the future or our strategic partners do not diligently pursue product development efforts, we may not be able to develop our technologies or products, which could slow our growth and decrease our value. We may be unable to raise additional capital, which would harm our ability to develop our technology and products. If conflicts arise between us and our collaborators, strategic partners, scientific advisors, or directors, these parties may act in their self-interest, which may limit our ability to implement our strategies. Our collaborations with outside scientists may be subject to change, which could limit our access to their expertise.

Full 10-K form ▸
related documents
908259--3/14/2006--OXIGENE_INC
805326--3/17/2008--EMISPHERE_TECHNOLOGIES_INC
1013238--3/31/2006--ARADIGM_CORP
908259--3/16/2010--OXIGENE_INC
1110803--3/6/2006--ILLUMINA_INC
1020214--2/27/2006--CERUS_CORP
1333248--3/16/2009--CADENCE_PHARMACEUTICALS_INC
897075--3/14/2007--REPROS_THERAPEUTICS_INC.
1001233--3/1/2007--SANGAMO_BIOSCIENCES_INC
908259--3/14/2007--OXIGENE_INC
908259--3/14/2008--OXIGENE_INC
874443--3/31/2006--GENELABS_TECHNOLOGIES_INC_/CA
72444--3/10/2010--NABI__BIOPHARMACEUTICALS
873303--3/10/2009--AVI_BIOPHARMA_INC
352747--3/16/2007--UNIGENE_LABORATORIES_INC
1120438--3/15/2006--THIRD_WAVE_TECHNOLOGIES_INC_/WI
873303--3/16/2010--AVI_BIOPHARMA_INC
887247--4/2/2007--CELLEGY_PHARMACEUTICALS_INC
1028358--3/31/2008--GENITOPE_CORP
1063665--9/23/2010--CORGENIX_MEDICAL_CORP/CO
318306--5/1/2006--ACCESS_PHARMACEUTICALS_INC
817785--4/4/2007--IMMUNE_RESPONSE_CORP
1023024--3/31/2006--BIOSANTE_PHARMACEUTICALS_INC
886163--3/31/2006--LIGAND_PHARMACEUTICALS_INC
1012270--3/16/2007--COLLAGENEX_PHARMACEUTICALS_INC
1010086--3/13/2008--SIGA_TECHNOLOGIES_INC
12239--4/4/2008--SPHERIX_INC
1017491--3/12/2008--NEXMED_INC
873303--3/16/2007--AVI_BIOPHARMA_INC
873303--3/16/2006--AVI_BIOPHARMA_INC